Methods for biomarker verification and assay development

Current Proteomics

Volumn 8, Issue 2, 2011, Pages 138-152

  Zhao, Yingxin ^a,b   Brasier, Allan R ^a,b,c  

^a Sealy Center for Molecular Medicine   (United States)

^b Departments of Internal Medicine   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Assay development; Biomarker verification; Mass spectrometry; Multiple reaction monitoring; Proteomics; Stable

Indexed keywords

BIOLOGICAL MARKER;

AFFINITY CHROMATOGRAPHY; ASTHMA; BREATH ANALYSIS; CHEMICAL LABELING; CHRONIC OBSTRUCTIVE LUNG DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUIPMENT DESIGN; EXHALED BREATH CONDENSATE; HUMAN; ISOBARIC TAG FOR RELATIVE AND ABSOLUTE QUANTIFICATION; ISOTOPE DILUTION ASSAY; ISOTOPE LABELING; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LUNG LAVAGE; MASS SPECTROMETRY; MULTIPLE REACTION MONITORING MASS SPECTROMETRY; PEPTIDE ANALYSIS; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PROCESS DESIGN; PROCESS DEVELOPMENT; PROCESS MONITORING; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; PROTEIN TARGETING; PROTEOMICS; QUANTITATIVE STUDY; REPRODUCIBILITY; RESPIRATORY TRACT DISEASE; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; SPECTRAL SENSITIVITY; SPUTUM ANALYSIS; STABLE ISOTOPE LABELING WITH AMINO ACID IN CELL CULTURE; STANDARD; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION STUDY;

EID: 79958275039     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016411795678066     Document Type: Review

References (103)

1. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 2001, 69(3), 89-95.
2. Ramaswamy, S. and Perou, C.M. DNA microarrays in breast cancer: the promise of personalised medicine. Lancet, 2003, 361(9369), 1576-1577.
3. Whitfield, M.L.; George, L.K.; Grant, G.D. and Perou, C.M. Common markers of proliferation. Nat. Rev. Cancer, 2006, 6(2), 99-106.
4. Rosenfeld, N.; Aharonov, R.; Meiri, E.; Rosenwald, S.; Spector, Y.; Zepeniuk, M.; Benjamin, H.; Shabes, N.; Tabak, S.; Levy, A.; Lebanony, D.; Goren, Y.; Silberschein, E.; Targan, N.; Ben-Ari, A.; Gilad, S.; Sion-Vardy, N.; Tobar, A.; Feinmesser, M.; Kharenko, O.; Nativ, O.; Nass, D.; Perelman, M.; Yosepovich, A.; Shalmon, B.; Polak-Charcon, S.; Fridman, E.; Avniel, A.; Bentwich, I.; Bentwich, Z.; Cohen, D.; Chajut, A. and Barshack, I. MicroRNAs accurately identify cancer tissue origin. Nat. Biotechnol., 2008, 26(4), 462-469.
5. Calin, G.A. and Croce, C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer, 2006, 6(11), 857-866.
6. Fernie, A.R.; Trethewey, R.N.; Krotzky, A.J. and Willmitzer, L. Metabolite profiling: from diagnostics to systems biology. Nat. Rev. Mol. Cell Biol., 2004, 5(9), 763-769.
7. Anderson, N.L. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin. Chem., 2010, 56(2), 177-185.
8. Plymoth, A.; Lofdahl, C.G.; Ekberg-Jansson, A.; Dahlback, M.; Broberg, P.; Foster, M.; Fehniger, T.E. and Marko-Varga, G. Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. Clin. Chem., 2007, 53(4), 636-644.
9. Plymoth, A.; Yang, Z.; Lofdahl, C.G.; Ekberg-Jansson, A.; Dahlback, M.; Fehniger, T.E.; Marko-Varga, G. and Hancock, W.S. Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never-smokers by micro-scale liquid chromatography and mass spectrometry. Clin. Chem., 2006, 52(4), 671-679.
10. Ohlmeier, S.; Vuolanto, M.; Toljamo, T.; Vuopala, K.; Salmenkivi, K.; Myllarniemi, M. and Kinnula, V.L. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J. Proteome Res., 2008, 7(12), 5125-5132.
11. Ong, S.E. and Mann, M. Stable isotope labeling by amino acids in cell culture for quantitative proteomics. Methods Mol. Biol., 2007, 359, 37-52.
12. Ong, S.E. Whole proteomes as internal standards in quantitative proteomics. Genome Med., 2010, 2(7), 49.
13. Song, X.; Bandow, J.; Sherman, J.; Baker, J.D.; Brown, P.W.; McDowell, M.T. and Molloy, M.P. ITRAQ experimental design for plasma biomarker discovery. J. Proteome Res., 2008, 7(7), 2952-2958.
14. Old, W.M.; Meyer-Arendt, K.; veline-Wolf, L.; Pierce, K.G.; Mendoza, A.; Sevinsky, J.R.; Resing, K.A. and Ahn, N.G. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol. Cell Proteomics, 2005, 4(10), 1487-1502.
15. Higgs, R.E.; Knierman, M.D.; Gelfanova, V.; Butler, J.P. and Hale, J.E. Label-free LC-MS method for the identification of biomarkers. Methods Mol. Biol., 2008, 428, 209-230.
16. Matsunaga, K.; Yanagisawa, S.; Ichikawa, T.; Ueshima, K.; Akamatsu, K.; Hirano, T.; Nakanishi, M.; Yamagata, T.; Minakata, Y. and Ichinose, M. Airway cytokine expression measured by means of protein array in exhaled breath condensate: correlation with physiologic properties in asthmatic patients. J. Allergy Clin. Immunol., 2006, 118(1), 84-90.
17. Kim, H.B.; Kim, C.K.; Iijima, K.; Kobayashi, T. and Kita, H. Protein microarray analysis in patients with asthma: elevation of the chemokine PARC/CCL18 in sputum. Chest, 2009, 135(2), 295-302.
18. Brasier, A.R.; Victor, S.; Boetticher, G.; Ju, H.; Lee, C.; Bleecker, E.R.; Castro, M.; Busse, W.W. and Calhoun, W.J. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J. Allergy Clin. Immunol., 2008, 121(1), 30-37.
19. Berezovski, M.V.; Lechmann, M.; Musheev, M.U.; Mak, T.W. and Krylov, S.N. Aptamer-facilitated biomarker discovery (AptaBiD). J. Am. Chem. Soc., 2008, 130(28), 9137-9143.
20. Carr, S.A. and Anderson, L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? Clin. Chem., 2008, 54(11), 1749-1752.
21. Cox, J. and Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol., 2008, 26(12), 1367-1372.
22. Ransohoff, D.F. Bias as a threat to the validity of cancer molecularmarker research. Nat. Rev. Cancer, 2005, 5(2), 142-149.
23. Rifai, N.; Gillette, M.A. and Carr, S.A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol., 2006, 24(8), 971-983.
24. Haab, B.B.; Dunham, M.J. and Brown, P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol., 2001, 2(2), RESEARCH0004.
25. LaBaer, J. and Ramachandran, N. Protein microarrays as tools for functional proteomics. Curr. Opin. Chem. Biol., 2005, 9(1), 14-19.
26. Gerber, S.A.; Rush, J.; Stemman, O.; Kirschner, M.W. and Gygi, S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA, 2003, 100(12), 6940-6945.
27. Beynon, R.J.; Doherty, M.K.; Pratt, J.M. and Gaskell, S.J. Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides. Nat. Methods, 2005, 2(8), 587-589.
28. Pratt, J.M.; Simpson, D.M.; Doherty, M.K.; Rivers, J.; Gaskell, S.J. and Beynon, R.J. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by Qcon- CAT genes. Nat. Protoc., 2006, 1(2), 1029-1043.
29. Lange, V.; Picotti, P.; Domon, B. and Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol. Syst. Biol., 2008, 4, 222.
30. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E. and Carr, S.A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell Proteomics, 2007, 6(12), 2212-2229.
31. Anderson, L. and Hunter, C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol. Cell Proteomics, 2006, 5(4), 573-588.
32. Wolf-Yadlin, A.; Hautaniemi, S.; Lauffenburger, D.A. and White, F.M. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc. Natl. Acad. Sci. USA, 2007, 104(14), 5860-5865.
33. Barnidge, D.R.; Dratz, E.A.; Martin, T.; Bonilla, L.E.; Moran, L.B. and Lindall, A. Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards. Anal. Chem., 2003, 75(3), 445-451.
34. Desiere, F.; Deutsch, E.W.; Nesvizhskii, A.I.; Mallick, P.; King, N.L.; Eng, J.K.; Aderem, A.; Boyle, R.; Brunner, E.; Donohoe, S.; Fausto, N.; Hafen, E.; Hood, L.; Katze, M.G.; Kennedy, K.A.; Kregenow, F.; Lee, H.; Lin, B.; Martin, D.; Ranish, J.A.; Rawlings, D.J.; Samelson, L.E.; Shiio, Y.; Watts, J.D.; Wollscheid, B.; Wright, M.E.; Yan, W.; Yang, L.; Yi, E.C.; Zhang H. and Aebersold, R. Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol., 2005, 6(1), R9.
35. Craig, R.; Cortens, J.P. and Beavis, R.C. Open source system for analyzing, validating, and storing protein identification data. J. Proteome Res., 2004, 3(6), 1234-1242.
36. Jones, P.; Cote, R.G.; Martens, L.; Quinn, A.F.; Taylor, C.F.; Derache, W.; Hermjakob, H. and Apweiler, R. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res., 2006, 34(Database issue), D659-D663.
37. Walsh, G.M.; Lin, S.; Evans, D.M.; Khosrovi-Eghbal, A.; Beavis, R.C. and Kast, J. Implementation of a data repository-driven approach for targeted proteomics experiments by multiple reaction monitoring. J. Proteomics, 2009, 72(5), 838-852.
38. Lange, V.; Malmstrom, J.A.; Didion, J.; King, N.L.; Johansson, B.P.; Schafer, J.; Rameseder, J.; Wong, C.H.; Deutsch, E.W.; Brusniak, M.Y.; Buhlmann, P.; Bjorck, L.; Domon, B. and Aebersold, R. Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring. Mol. Cell Proteomics, 2008, 7(8), 1489-1500.
39. Deutsch, E.W.; Lam, H. and Aebersold, R. Peptide Atlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep., 2008, 9(5), 429-434.
40. Mallick, P.; Schirle, M.; Chen, S.S.; Flory, M.R.; Lee, H.; Martin, D.; Ranish, J.; Raught, B.; Schmitt, R.; Werner, T.; Kuster, B. and Aebersold, R. Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol., 2007, 25(1), 125-131.
41. Sanders, W.S.; Bridges, S.M.; McCarthy, F.M.; Nanduri, B. and Burgess, S.C. Prediction of peptides observable by mass spectrometry applied at the experimental set level. BMC Bioinformatics, 2007, 8 Suppl 7, S23.
42. Tang, H.; Arnold, R.J.; Alves, P.; Xun, Z.; Clemmer, D.E.; Novotny, M.V.; Reilly, J.P. and Radivojac, P. A computational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics, 2006, 22(14), e481-e488.
43. Webb-Robertson, B.J.; Cannon, W.R.; Oehmen, C.S.; Shah, A.R.; Gurumoorthi, V.; Lipton, M.S. and Waters, K.M. A support vector machine model for the prediction of proteotypic peptides for accurate mass and time proteomics. Bioinformatics, 2008, 24(13), 1503-1509.
44. Fusaro, V.A.; Mani, D.R.; Mesirov, J.P. and Carr, S.A. Prediction of high-responding peptides for targeted protein assays by mass spectrometry. Nat. Biotechnol., 2009, 27(2), 190-198.
45. Frank, A.M. Predicting intensity ranks of peptide fragment ions. J. Proteome Res., 2009, 8(5), 2226-2240.
46. Picotti, P.; Rinner, O.; Stallmach, R.; Dautel, F.; Farrah, T.; Domon, B.; Wenschuh, H. and Aebersold, R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nat. Methods, 2010, 7(1), 43-46.
47. Picotti, P.; Bodenmiller, B.; Mueller, L.N.; Domon, B. and Aebersold, R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell, 2009, 138(4), 795-806.
48. Keshishian, H.; Addona, T.; Burgess, M.; Mani, D.R.; Shi, X.; Kuhn, E.; Sabatine, M.S.; Gerszten, R.E. and Carr, S.A. Quantificationof cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell Proteomics, 2009, 8(10), 2339-2349.
49. Kuzyk, M.A.; Smith, D.; Yang, J.; Cross, T.J.; Jackson, A.M.; Hardie, D.B.; Anderson, N.L. and Borchers, C.H. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell Proteomics, 2009, 8(8), 1860-1877.
50. Brun, V.; Masselon, C.; Garin, J. and Dupuis, A. Isotope dilution strategies for absolute quantitative proteomics. J. Proteomics, 2009, 72(5), 740-749.
51. Havlis, J. and Shevchenko, A. Absolute quantification of proteins in solutions and in polyacrylamide gels by mass spectrometry. Anal. Chem., 2004, 76(11), 3029-3036.
52. Mirzaei, H.; McBee, J.K.; Watts, J. and Aebersold, R. Comparative evaluation of current peptide production platforms used in absolute quantification in proteomics. Mol. Cell Proteomics, 2008, 7(4), 813-823.
53. Kito, K.; Ota, K.; Fujita, T. and Ito, T. A synthetic protein approach toward accurate mass spectrometric quantification of component stoichiometry of multiprotein complexes. J. Proteome Res., 2007, 6(2), 792-800.
54. Brun, V.; Dupuis, A.; Adrait, A.; Marcellin, M.; Thomas, D.; Court, M.; Vandenesch, F. and Garin, J. Isotope-labeled protein standards: toward absolute quantitative proteomics. Mol. Cell Proteomics, 2007, 6(12), 2139-2149.
55. Dupuis, A.; Hennekinne, J.A.; Garin, J. and Brun, V. Protein standard absolute quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks. Proteomics, 2008, 8(22),4633-4636.
56. Kuhn, E.; Addona, T.; Keshishian, H.; Burgess, M.; Mani, D.R.; Lee, R.T.; Sabatine, M.S.; Gerszten, R.E. and Carr, S.A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem., 2009, 55(6), 1108-1117.
57. Ahn, Y.H.; Lee, J.Y.; Lee, J.Y.; Kim, Y.S.; Ko, J.H. and Yoo, J.S. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. J. Proteome Res., 2009, 8(9), 4216-4224.
58. Addona, T.A.; Abbatiello, S.E.; Schilling, B.; Skates, S.J.; Mani, D.R.; Bunk, D.M.; Spiegelman, C.H.; Zimmerman, L.J.; Ham, A.J.; Keshishian, H.; Hall, S.C.; Allen, S.; Blackman, R.K.; Borchers, C.H.; Buck, C.; Cardasis, H.L.; Cusack, M.P.; Dodder, N.G.; Gibson, B.W.; Held, J.M.; Hiltke, T.; Jackson, A.; Johansen, E.B.; Kinsinger, C.R.; Li, J.; Mesri, M.; Neubert, T.A.; Niles, R.K.; Pulsipher, T.C.; Ransohoff, D.; Rodriguez, H.; Rudnick, P.A.; Smith, D.; Tabb, D.L.; Tegeler, T.J.; Variyath, A.M.; Vega-Montoto, L.J.; Wahlander, A.; Waldemarson, S.; Wang, M.; Whiteaker, J.R.; Zhao, L.; Anderson, N.L.; Fisher, S.J.; Liebler, D.C.; Paulovich, A.G.; Regnier, F.E.; Tempst, P. and Carr, S.A. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring- based measurements of proteins in plasma. Nat. Biotechnol., 2009, 27(7), 633-641.
59. Hoofnagle, A.N.; Becker, J.O.; Wener, M.H. and Heinecke, J.W. Quantification of thyroglobulin, a low-abundance serum protein, byimmunoaffinity peptide enrichment and tandem mass spectrometry. Clin. Chem., 2008, 54(11), 1796-1804.
60. Linnet, K. and Kondratovich, M. Partly nonparametric approach for determining the limit of detection. Clin. Chem., 2004, 50(4), 732-740.
61. Stahl-Zeng, J.; Lange, V.; Ossola, R.; Eckhardt, K.; Krek, W.; Aebersold, R. and Domon, B. High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol. Cell Proteomics, 2007, 6(10), 1809-1817.
62. Ahn, Y.H.; Lee, J.Y.; Lee, J.Y.; Kim, Y.S.; Ko, J.H. and Yoo, J.S. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. J. Proteome Res., 2009, 8(9), 4216-4224.
63. Nicol, G.R.; Han, M.; Kim, J.; Birse, C.E.; Brand, E.; Nguyen, A.; Mesri, M.; FitzHugh, W.; Kaminker, P.; Moore, P.A.; Ruben, S.M. and He, T. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Mol. Cell Proteomics, 2008, 7(10), 1974-1982.
64. Tuerk, C. and Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science, 1990, 249(4968), 505-510.
65. Nery, A.A.; Wrenger, C. and Ulrich, H. Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agents. J. Sep. Sci., 2009, 32(10), 1523-1530.
66. Anderson, N.L.; Anderson, N.G.; Haines, L.R.; Hardie, D.B.; Olafson, R.W. and Pearson, T.W. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). J. Proteome Res., 2004, 3(2), 235-244.
67. Whiteaker, J.R.; Zhao, L.; Zhang, H.Y.; Feng, L.C.; Piening, B.D.; Anderson, L. and Paulovich, A.G. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Anal. Biochem., 2007, 362(1), 44-54.
68. Whiteaker, J.R.; Zhao, L.; Anderson, L. and Paulovich, A.G. An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers. Mol. Cell Proteomics, 2010, 9(1), 184-196.
69. Schoenherr, R.M.; Zhao, L.; Whiteaker, J.R.; Feng, L.C.; Li, L.; Liu, L.; Liu, X. and Paulovich, A.G. Automated screening of monoclonal antibodies for SISCAPA assays using a magnetic bead processor and liquid chromatography-selected reaction monitoringmass spectrometry. J. Immunol. Methods, 2010, 353(1-2), 49-61.
70. Lopez, M.F.; Rezai, T.; Sarracino, D.A.; Prakash, A.; Krastins, B.; Athanas, M.; Singh, R.J.; Barnidge, D.R.; Oran, P.; Borges, C. and Nelson, R.W. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clin. Chem., 2010, 56(2), 281-290.
71. Fortin, T.; Salvador, A.; Charrier, J.P.; Lenz, C.; Bettsworth, F.; Lacoux, X.; Choquet-Kastylevsky, G. and Lemoine, J. Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum. Anal. Chem., 2009, 81(22), 9343-9352.
72. Kelly, R.T.; Page, J.S.; Zhao, R.; Qian, W.J.; Mottaz, H.M.; Tang, K. and Smith, R.D. Capillary-based multi nanoelectrospray emitters: improvements in ion transmission efficiency and implementation with capillary reversed-phase LC-ESI-MS. Anal. Chem., 2008, 80(1), 143-149.
73. Page, J.S.; Tang, K.; Kelly, R.T. and Smith, R.D. Subambient pressure ionization with nanoelectrospray source and interface for improved sensitivity in mass spectrometry. Anal. Chem., 2008, 80(5), 1800-1805.
74. Sherman, J.; McKay, M.J.; Ashman, K. and Molloy, M.P. How specific is my SRM?: The issue of precursor and product ion redundancy. Proteomics, 2009, 9(5), 1120-1123.
75. Matuszewski, B.K.; Constanzer, M.L. and Chavez-Eng, C.M. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at pictogram per milliliter concentrations. Anal. Chem., 1998, 70(5), 882-889.
76. King, R.; Bonfiglio, R.; Fernandez-Metzler, C.; Miller-Stein, C. and Olah, T. Mechanistic investigation of ionization suppression in electrospray ionization. J. Am. Soc. Mass Spectrom., 2000, 11(11), 942-950.
77. Abbatiello, S.E.; Mani, D.R.; Keshishian, H. and Carr, S.A. Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry. Clin. Chem., 2010, 56(2), 291-305.
78. Yan, Z.; Maher, N.; Torres, R.; Cotto, C.; Hastings, B.; Dasgupta, M.; Hyman, R.; Huebert, N. and Caldwell, G.W. Isobaric metabolite interferences and the requirement for close examination of raw data in addition to stringent chromatographic separations in liquid chromatography/tandem mass spectrometric analysis of drugs in biological matrix. Rapid Commun. Mass Spectrom., 2008, 22(13), 2021-2028.
79. Borrill, Z.L.; Roy, K. and Singh, D. Exhaled breath condensate biomarkers in COPD. Eur. Respir. J., 2008, 32(2), 472-486.
80. Chen, H.; Wang, D.; Bai, C. and Wang, X. Proteomics-Based Biomarkers in Chronic Obstructive Pulmonary Disease. J. Proteome Res., 2010, 9(6), 2798-2808.
81. Casado, B.; Iadarola, P.; Luisetti, M. and Kussmann, M. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers. Expert Rev. Proteomics, 2008, 5(5), 693-704.
82. Snell, N. and Newbold, P. The clinical utility of biomarkers in asthma and COPD. Curr. Opin. Pharmacol., 2008, 8(3), 222-235.
83. Plymoth, A.; Lofdahl, C.G.; Ekberg-Jansson, A.; Dahlback, M.; Lindberg, H.; Fehniger, T.E. and Marko-Varga, G. Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics, 2003, 3(6), 962-972.
84. Barnes, P.J.; Chowdhury, B.; Kharitonov, S.A.; Magnussen, H.; Page, C.P.; Postma, D. and Saetta, M. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit Care Med., 2006, 174(1), 6-14.
85. Wattiez, R.; Hermans, C.; Cruyt, C.; Bernard, A. and Falmagne, P. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Electrophoresis, 2000, 21(13), 2703-2712.
86. Djukanovic, R.; Sterk, P.J.; Fahy, J.V. and Hargreave, F.E. Standardised methodology of sputum induction and processing. Eur. Respir. J. Suppl., 2002, 37, 1s-2s.
87. Thomas, R.A.; Green, R.H.; Brightling, C.E.; Birring, S.S.; Parker, D.; Wardlaw, A.J. and Pavord, I.D. The influence of age on induced sputum differential cell counts in normal subjects. Chest, 2004, 126(6), 1811-1814.
88. Carpagnano, G.E.; Foschino, B.M.P.; Resta, O.; Gramiccioni, E.; Valerio, N.V.; Bracciale, P. and Valerio, G. Exhaled markers in the monitoring of airways inflammation and its response to steroid's treatment in mild persistent asthma. Eur. J. Pharmacol., 2005, 519(1-2), 175-181.
89. Carpagnano, G.E.; Barnes, P.J.; Geddes, D.M.; Hodson, M.E. and Kharitonov, S.A. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am. J. Respir. Crit. Care Med., 2003, 167(8), 1109-1112.
90. Liu, J.; Conrad, D.H.; Chow, S.; Tran, V.H.; Yates, D.H. and Thomas, P.S. Collection devices influence the constituents of exhaled breath condensate. Eur. Respir. J., 2007, 30(4), 807-808.
91. Rosias, P.P.; Robroeks, C.M.; Niemarkt, H.J.; Kester, A.D.; Vernooy, J.H.; Suykerbuyk, J.; Teunissen, J.; Heynens, J.; Hendriks, H.J.; Jobsis, Q. and Dompeling, E. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate. Eur. Respir. J., 2006, 28(5), 1036-1041.
92. Horvath, I.; Hunt, J.; Barnes, P.J.; Alving, K.; Antczak, A.; Baraldi, E.; Becher, G.; van Beurden, W.J.; Corradi, M.; Dekhuijzen, R.; Dweik, R.A.; Dwyer, T.; Effros, R.; Erzurum, S.; Gaston, B.; Gessner, C.; Greening, A.; Ho, L.P.; Hohlfeld, J.; Jobsis, Q.; Laskowski, D.; Loukides, S.; Marlin, D.; Montuschi, P.; Olin, A.C.; Redington, A.E.; Reinhold, P.; van Rensen, E.L.; Rubinstein, I.; Silkoff, P.; Toren, K.; Vass, G.; Vogelberg, C. and Wirtz, H. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur. Respir. J., 2005, 26(3), 523-548.
93. Effros, R.M.; Biller, J.; Foss, B.; Hoagland, K.; Dunning, M.B.; Castillo, D.; Bosbous, M.; Sun, F. and Shaker, R. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am. J. Respir. Crit. Care Med., 2003, 168(12), 1500-1505.
94. Gessner, C.; Kuhn, H.; Seyfarth, H.J.; Pankau, H.; Winkler, J.; Schauer, J. and Wirtz, H. Factors influencing breath condensate volume. Pneumologie, 2001, 55(9), 414-419.
95. Effros, R.M.; Hoagland, K.W.; Bosbous, M.; Castillo, D.; Foss, B.; Dunning, M.; Gare, M.; Lin, W. and Sun, F. Dilution of respiratory solutes in exhaled condensates. Am. J. Respir. Crit. Care Med., 2002, 165(5), 663-669.
96. US Food and Drugs Administration Guidance for industry on bioanalytical method validation. US Food and Drugs Administration [online] 2001, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
97. Lee, J.W.; Devanarayan, V.; Barrett, Y.C.; Weiner, R.; Allinson, J.; Fountain, S.; Keller, S.; Weinryb, I.; Green, M.; Duan, L.; Rogers, J.A.; Millham, R.; O'Brien, P.J.; Sailstad, J.; Khan, M.; Ray C. and Wagner, J.A. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res., 2006, 23(2), 312-328.
98. Gutman, S. and Kessler, L.G. The US Food and Drug Administration perspective on cancer biomarker development. Nat. Rev. Cancer, 2006, 6(7), 565-571.
99. US Food and Drugs Administration Draft guidance for industry and FDA stall - pharmacogenetic tests and genetic tests for heritable markers. US Food and Drugs Administration [online] 2006,(http://www.fda.gov/cdrh/oivd/guidance/1549.html).
100. US Food and Drugs Administration Statistical Guidance on reporting results from studies evaluating diagnostic test; draft guidance for industry and FDA reviewers. US Food and Drugs Administration [online] 2003,(http://www.fda.gov/cdrh/osb/guidance/1428.html).
101. Ellington, A.A.; Kullo, I.J.; Bailey, K.R. and Klee, G.G. Antibodybased protein multiplex platforms: technical and operational challenges. Clin. Chem., 2010, 56(2), 186-193.
102. Regnier, F.E.; Skates, S.J.; Mesri, M.; Rodriguez, H.; Tezak, Z.; Kondratovich, M.V.; Alterman, M.A.; Levin, J.D.; Roscoe, D.; Reilly, E.; Callaghan, J.; Kelm, K.; Brown, D.; Philip, R.; Carr, S.A.; Liebler, D.C.; Fisher, S.J.; Tempst, P.; Hiltke, T.; Kessler, L.G.; Kinsinger, C.R.; Ransohoff, D.F.; Mansfield, E. and Anderson, N.L. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin. Chem., 2010, 56(2), 165-171.
103. Rodriguez, H.; Tezak, Z.; Mesri, M.; Carr, S.A.; Liebler, D.C.; Fisher, S.J.; Tempst, P.; Hiltke, T.; Kessler, L.G.; Kinsinger, C.R.; Philip, R.; Ransohoff, D.F.; Skates, S.J.; Regnier, F.E.; Anderson, N.L. and Mansfield, E. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. Clin. Chem., 2010, 56(2), 237-243.